#thrombogenicity

Early outpatient use of low-molecular-weight heparin benefits COVID-19 outcome in association with hospitalization - Lessons learned Covid-19 and venous thromboembolism (VTE) share risk factors and thrombo-inflammatory pathophysiology. In-hospital low-molecular-weight heparin (LMWH)…

While being #Covid aftermath, the study is relevant for any other severe viral outbursts associated with #thrombogenicity.

www.sciencedirect.com/science/arti...

Dr. Monica Hinds sharing an overview of her lab’s productivity, including studying #TAVR leaflet degradation, cardiac device #thrombogenicity and more at @OHSUCardio KCVI Research Retreat 2025 @OHSUSOM @OHSUNews 🫀🦾🦿🤖🩸